Search research articles
Contact Us
Filters
Showing results (141-150 of 187) with videos related to
Page
of 19
Sort By:
Oncogene
|
May 18, 2005
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth
Deborah A Altomare, Huihong You, Guang-Hui Xiao, et al.
International Journal of Cancer
|
November 1, 2008
Genomic events associated with progression of pleural malignant mesothelioma
Sergey V Ivanov, Jeremy Miller, Robert Lucito, et al.
Plos One
|
April 29, 2011
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis
Deborah A Altomare, Craig W Menges, Jinfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary
Seiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
The Journal of Urology
|
November 26, 2015
Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features
Timothy Ito, Jianming Pei, Essel Dulaimi, et al.
Molecular Carcinogenesis
|
April 2, 2004
Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cells
Mohamed H Lareef, Quivo Tahin, Joon Song, et al.
International Journal of Cancer
|
June 29, 2011
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas
Arti Shukla, Jedd M Hillegass, Maximilian B MacPherson, et al.
Cancer Research
|
March 5, 2008
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice
Yinfei Tan, Roman A Timakhov, Mamta Rao, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling
Eleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study
Linda L Garland, Cathryn Rankin, David R Gandara, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 187) with videos related to
Sort By:
Page
of 19
Oncogene
|
May 18, 2005
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth
Deborah A Altomare, Huihong You, Guang-Hui Xiao, et al.
International Journal of Cancer
|
November 1, 2008
Genomic events associated with progression of pleural malignant mesothelioma
Sergey V Ivanov, Jeremy Miller, Robert Lucito, et al.
Plos One
|
April 29, 2011
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis
Deborah A Altomare, Craig W Menges, Jinfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary
Seiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
The Journal of Urology
|
November 26, 2015
Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features
Timothy Ito, Jianming Pei, Essel Dulaimi, et al.
Molecular Carcinogenesis
|
April 2, 2004
Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cells
Mohamed H Lareef, Quivo Tahin, Joon Song, et al.
International Journal of Cancer
|
June 29, 2011
ERK2 is essential for the growth of human epithelioid malignant mesotheliomas
Arti Shukla, Jedd M Hillegass, Maximilian B MacPherson, et al.
Cancer Research
|
March 5, 2008
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice
Yinfei Tan, Roman A Timakhov, Mamta Rao, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling
Eleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2007
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study
Linda L Garland, Cathryn Rankin, David R Gandara, et al.
Page
of 19